Cochrane warmly invites you to submit abstracts for oral presentations, posters, and workshops for the second Global Evidence Summit (GES) 2024. Hosted by global leaders in evidence synthesis and evidence-based practice, including Cochrane, JBI, Guidelines International Network (GIN), and The Campbell Collaboration, the summit is set to take place in the historical city of Prague, Czech Republic, from 10 to 13 September 2024, with satellite meetings on 9 September 2024.
This collaborative effort between esteemed organizations represents a unique opportunity for professionals across various sectors, such as health, education, social justice, the environment, and climate change, to engage in discussions about producing, summarizing, and disseminating evidence to inform policy and practice. Abstract and workshop submissions will be accepted until the extended deadline of 6 March 2024.
Dr. Karla Soares-Weiser, Vice Chair of the GES Scientific Committee and Cochrane Editor in Chief, extends an invitation to the Cochrane community, emphasizing the importance of their participation in this global event:
As we open the doors for abstract submissions to the second Global Evidence Summit, I am thrilled to invite the Cochrane community to contribute to the exchange of ideas that will shape the future of evidence-based practice. This summit, uniting leading organizations in evidence synthesis, is a testament to our commitment to improving lives worldwide through the power of credible evidence. I encourage all Cochrane members and supporters to submit their abstracts for oral presentations, posters, or workshops, and join us in Prague for this exceptional opportunity to collaborate, learn, and drive positive change.
The themes for GES 2024 include:
- Sustainable development agenda
- The importance of research integrity making evidence accessible
- Power of synergy in evidence synthesis & synthesis products
- Evidence translation & implementation
- Advocating for greater evidence communication & use of evidence
- From global evidence to local impactImage
Catherine Spencer, Cochrane's CEO, emphasizing the significance of the GES in fostering synergies and knowledge sharing within the global evidence community:
Our recent Cochrane Colloquium in London was a testament to the vibrant spirit of the Cochrane community. In 2024, we are excited to co-host the second Global Evidence Summit alongside our esteemed partners. GES provides a crucial platform to address vital issues across sectors, while showcasing the incredible methods and work of Cochrane. I warmly invite all Cochrane members to participate actively and submit abstracts. Let's unite for #GES2024 and contribute to advancing evidence-based practice globally!
Abstracts and workshop submissions are open until 6 March 2024 with notifications of acceptances happening on 30 April 2024.
